Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Autor: Segal, Neil H., Ou, Sai-Hong I., Balmanoukian, Ani, Fury, Matthew G., Massarelli, Erminia, Brahmer, Julie R., Weiss, Jared, Schöffski, Patrick, Antonia, Scott J., Massard, Christophe, Zandberg, Dan P., Khleif, Samir N., Xiao, Feng, Rebelatto, Marlon C., Steele, Keith E., Robbins, Paul B., Angra, Natasha, Song, Xuyang, Abdullah, Shaad, Butler, Marcus
Zdroj: In European Journal of Cancer March 2019 109:154-161
Databáze: ScienceDirect
Externí odkaz: